Scientists Successfully Upload Entire Viral Genome to Quantum Computer for First Time

Researchers encoded the complete genome of hepatitis D virus onto IBM's 156-qubit Heron quantum processor, marking the first time an entire viral genome has been uploaded to a quantum computer. The achievement was accomplished as part of the Quantum for Bio (Q4Bio) challenge, an international research competition focused on advancing quantum computing applications in human health. This milestone demonstrates that quantum computers can process real-world genomic data, potentially opening new avenues for biological research and medical applications.
In a significant breakthrough for quantum computing applications in biology, scientists have successfully encoded the entire genome of hepatitis D virus (HDV) onto IBM's 156-qubit Heron quantum processing unit. This represents the first time researchers have uploaded a complete viral genome to a quantum computer system. The achievement was accomplished through participation in the Quantum for Bio (Q4Bio) challenge, a competitive international research program designed to accelerate the development of quantum computing applications for human health. The successful encoding demonstrates that quantum computers can handle and process real-world genomic data in formats compatible with quantum systems. This milestone is considered an important step toward practical applications of quantum computing in biological research and medicine.
Limitations & open questions
The specific methods used to translate the viral genome into a quantum-readable format are not detailed. Additionally, the practical applications or next steps following this achievement, and how this compares to classical computing approaches for genome analysis, are not discussed.
What different sources said
- Live ScienceCenter
In a first, scientists translated an entire viral genome so a quantum computer could read and analyze it
Related
Computational Study Identifies Plant-Derived Peptide as Potential MDM2-p53 Inhibitor
Researchers used computational screening of plant proteomes to identify SPAFESTWDILK, a 12-amino-acid peptide from ginger, as a predicted binder to MDM2—a protein that regulates the tumor suppressor p53. The discovery employed multiple computational methods including AlphaFold 3 co-folding and molecular dynamics simulations, with results showing consistent binding predictions across eight different assessments. The finding is significant because no food-derived linear peptide has previously been documented to engage the MDM2-p53 interface, though the authors acknowledge that experimental validation is needed.
Active Learning Framework Guides Design of Peptides to Modulate Biomolecular Condensate Properties
Researchers used active learning combined with molecular dynamics simulations to design peptide variants that can tune the physical properties of biomolecular condensates, specifically studying the MUT-16 condensate in C. elegans. The approach integrates Bayesian optimization with neural networks to efficiently identify peptide sequences that modulate condensate behavior while reducing computational requirements. This work could enable rational engineering of synthetic condensates and inform therapeutic strategies for diseases linked to condensate dysfunction, including neurodegenerative disorders.

Researchers Develop 'Molecular Eraser' to Destroy Cancer-Causing mRNA Before Protein Forms
Scientists at the Max Planck Institute have created a new therapeutic approach that targets and destroys mRNA of the NRAS cancer protein before it can be translated into protein. RAS mutations are responsible for many of the deadliest cancers, but effective treatments have remained elusive. This mRNA-targeting strategy could represent a new avenue for treating previously difficult-to-address cancers.